Skip to main content

Polymers in Mucoadhesive Drug Delivery System: A Brief Note

 

Clinical courses

About Authors: NIDHI KARIA1*, RAKHI CHANDAK1, ARATI  RATHI2
1. P.WADHWANI COLLEGE OF PHARMACY,YAVATMAL
2. ASST PROFFESER AT SUMANDEEP DEPARMENT OF PHARMACY, VADODARA

Abstract:
Bioadhesion can be defined as the process by which a natural or a synthetic polymer can adhere to a biological substrate. When the biological substrate is a mucosal layer then the phenomena is known as mucoadhesion. The substrate possessing bioadhesive property can help in devising a delivery system capable of delivering a bioactive agent for a prolonged period of time at a specific delivery site. The current review  provides  a good insight on mucoadhesive polymers, the phenomenon of mucoadhesion and the factors which have the ability to affect the mucoadhesive properties of a polymer.

Reference Id: PHARMATUTOR-ART-1177

INTRODUCTION
Bioadhesion can be defined as a phenomenon of interfacial molecular attractive forces amongst the surfaces of the biological substrate and the natural or synthetic polymers, which allows the polymer to adhere to the  biological surface for an extended period of time [1-4]. Bioadhesive polymeric systems have been used since long time in the development of products for various biomedical applications which include denture adhesives and surgical glue [5-8]. The adhesion of bacteria to the human gut may be attributed to the interaction of lectin-like structure (present on the cell surface of bacteria) and mucin (present in the biological tissues) [9-12]. In general, various  biopolymers  show  the  bioadhesive  properties  and  have  been  utilized  for  various therapeutic purposes in medicine [2, 13]. The bioadhesive polymers can be broadly classified into two groups, namely specific and nonspecific [14]. The specific bioadhesive polymers (e.g. lectins, fimbrin) have the ability to adhere to specific chemical structures within the biological molecules while  the nonspecific bioadhesive polymers (e.g. polyacrylic acid, cyanoacrylates) have the ability to bind with both the cell surfaces and the mucosal layer.
The use of mucoadhesive polymers for the development of pharmaceutical formulations dates back to 1947,  when attempts were made to formulate a penicillin drug delivery system for delivering the bioactive agent to  the oral mucosa using gum tragacanth and dental adhesive powders [15].  Improved  results were reported  when carboxymethylcellulose and petrolatum were  used  for  the  development  of  the  formulation.  Subsequent   research  resulted  in  the development  of  a  mucoadhesive  delivery vehicle  which  consisted  of  finely  ground  sodium carboxymethylcellulose (SCMC), pectin, and gelatin. The formulation was later marketed as Orahesive®. Another formulation which entered into the clinical trials is Orabase®, which is a blend of  polymethylene/ mineral oil base. This was followed by the development of a system where polyethylene sheet  was laminated with a blend of sodium carboxymethylcellulose and poly (isobutylene) which provided an added advantage of protecting the mucoadhesive layer by the polyethylene backing from the physical interference of the external environment [16-18].
Over the years, various other polymers (e.g. sodium alginate, sodium carboxymethylcellulose, guar gum, hydroxyethylcellulose, karya gum, methylcellulose, polyethylene glycol (PEG), retene and tragacanth) have been found to exhibit mucoadhesive properties. During the period of 1980s poly (acrylic acid), hydroxypropylcellulose,  and sodium carboxymethylcellulose were widely explored for the development of formulations having mucoadhesive properties. Since then the use of acrylate polymers for the development of mucoadhesive  formulations have increased many-fold, various authors have investigated the mucoadhesive properties of different polymers with varying molecular architecture [19-21]. After a lot of research, the researchers are of the view  that  a  polymer  will  exhibit  sufficient  mucoadhesive  property  if  it  can  form  strong intermolecular hydrogen  bonding with the mucosal layer, penetration of the polymer into the mucus network or tissue crevices, easy wetting of mucosal layer and high molecular weight of the polymer chain. The ideal characteristics of a mucoadhesive polymer matrix include the rapid adherence to the mucosal layer without any change in the  physical property of the delivery matrix, minimum interference to the release of the active agent, biodegradable without producing any toxic byproducts, inhibit the enzymes present at the delivery site and enhance the penetration of the active agent (if the active agent is meant to be absorbed from the delivery site) [22].

Before discussing  about  the commonly used  mucoadhesive  polymers,  the different  theories which have been  proposed to explain the phenomenon of mucoadhesion will be discussed. Furthermore, different factors affecting mucoadhesion, methods of evaluation of mucoadhesive properties  of  polymers  and  the  potential  biological  sites  where  mucoadhesion  can  play  an important role will be taken up for discussion.

THEORIES OF MUCOADHESION
The phenomena of bioadhesion occurs by a complex mechanism. Till date, six theories have been proposed  which can improve our understanding for the phenomena of adhesion and can also  be  extended  to  explain  the  mechanism  of  bioadhesion.  The  theories  include:  (a)  the electronic theory, (b) the wetting theory, (c) the adsorption theory, (d) the diffusion theory, (e) the mechanical theory and (f) the cohesive theory. The electronic  theory proposes transfer of electrons amongst the surfaces resulting in the formation of an electrical double layer  thereby giving rise to attractive forces. The wetting theory postulates that if the contact angle of liquids on the substrate surface is lower, then there is a greater affinity for the liquid to the substrate surface. If two such substrate surfaces are brought in contact with each other in the presence of the liquid, the liquid may act as an  adhesive amongst the substrate surfaces. The adsorption theory proposes the presence of intermolecular forces,  viz. hydrogen  bonding and  Van der Waal’s forces, for the adhesive interaction amongst the substrate surfaces. The diffusion theory assumes  the  diffusion  of  the  polymer  chains,  present  on  the  substrate  surfaces,  across  the adhesive interface thereby forming a networked structure. The mechanical theory explains the diffusion of the liquid adhesives into the micro-cracks and irregularities present on the substrate surface thereby forming an  interlocked structure which gives rise to adhesion. The cohesive theory  proposes  that  the  phenomena  of  bioadhesion  are  mainly  due  to  the  intermolecular interactions amongst like-molecules [23-24].
Based on the above theories, the process of bioadhesion can be broadly classified into two categories, namely chemical (electronic and adsorption theories) and physical (wetting, diffusion and cohesive theory) methods [25-26]. The process of adhesion may be divided into two stages. During the first stage (also known as contact  stage), wetting of mucoadhesive polymer and mucous membrane occurs followed by the consolidation stage,  where the physico-chemical interactions prevail [27-28].
 
As mentioned above, bioadhesion may take place either by physical or by chemical interactions. These  interactions  can  be  further  classified  as  hydrogen  bonds,  Van  der  Waals  force  and hydrophobic bonds which  are considered as physical interactions while the formation of ionic and covalent bonds are categorized as chemical interactions. Hydrogen bonds are formed due to the interaction of the electronegative and electropositive atoms though there is no actual transfer of electrons. Example of this kind of interaction includes formation of  gelled structure when aqueous solutions of polyvinyl alcohol and glycine are mixed. Van der Waals forces are either due to presence of the dipole-dipole interactions in polar molecules or due to the dispersion forces amongst non-polar substrates. Hydrophobic bonds are formed due to the interaction of the non-polar groups when  the polymers are dispersed in an aqueous solution. Freeze-thawing of polyvinyl alcohol solution in water exhibits this kind of interaction.  Ionic bonds are formed due to the electrostatic interactions amongst the polymers (e.g.  instantaneous formation of gelled structure when alginate and chitosan solutions in water are mixed) while  covalent bonds are formed due to the sharing of electrons amongst the atoms (e.g. crosslinking reaction amongst genipin and amino groups).
The term “mucoadhesion” was coined for the adhesion of the polymers with the surface of the mucosal layer [29]. The mucosal layer is made up of mucus which is secreted by the goblet cells (glandular columnar epithelial cells) and is a viscoelastic fluid. It lines the visceral organs, which are exposed to the external environment. The main components constituting the mucosa include water and mucin (an anionic polyelectrolyte), while the other components include proteins, lipids and mucopolysaccharides. Water and mucin constitute > 99% of the total  composition of the mucus and out of this > 95% is water. The gel-like structure of the mucus can be attributed to the intermolecular   entanglements   of   the   mucin   glycoproteins   along   with   the   non-covalent interactions (e.g. hydrogen, electrostatic and hydrophobic bonds) which results in the formation of a hydrated gel-like structure and explains the viscoelastic nature of the mucus [24].

NOW YOU CAN ALSO PUBLISH YOUR ARTICLE ONLINE.

SUBMIT YOUR ARTICLE/PROJECT AT articles@pharmatutor.org

Subscribe to Pharmatutor Alerts by Email

FIND OUT MORE ARTICLES AT OUR DATABASE

FACTORS AFFECTING MUCOADHESION
Based on the theories of the adhesion, it can be summarized that the mucoadhesive property of a polymer  can  be  tailored  by  changing  the  parameters  which  has  the  capacity  to  alter  the interaction among the polymer and the mucosal layer. In this section, attempts will be made to analyze some of the parameters which can tailor the mucoadhesive property of a given polymer.

Polymers usually diffuse into the mucosal layer and thereafter adhere to the layer by forming intermolecular entanglements. With the increase in the molecular weight (MW) of the polymer chain there is an increase in the mucoadhesiveness of a polymer. In general, polymers having MW ≥ 100, 000 have been found to have  adequate mucoadhesive property for biomedical applications.  A  typical  example  is  polyethylene  glycol  (PEG).  PEG  of  20,000  MW  shows negligible    mucoadhesive    property    while    PEG    of    200,000    MW    exhibits    improved mucoadhesiveness  and  the PEG  of 400,000  MW  has  got  excellent  mucoadhesiveness  [30]. Similarly, polyoxyethylene of 7,000,000 MW has exhibited excellent mucoadhesive  property and could be tried for the development of buccal delivery systems [31]. Dextrans of 19,500,000 and 200,000 MW, poly(acrylic) acid of ~750,000 MW and polyethylene oxide of 4,000,000 MW also exhibit good  bioadhesive property [24]. Polymer chain length plays an important role in bioadhesiveness. With the increase in the chain length of the polymers there is an increase in the mucoadhesive property of the polymer. Flexible polymer chains helps in the better penetration and entanglement of the polymer chains with  that of mucosal  layer thereby improving the bioadhesive  property.  The  flexibility  of  the  polymer  chains  is  generally  affected  by  the crosslinking reactions and the hydration of the polymer network. Higher the crosslinking density, lower is the flexibility of the polymer chains. Keeping this in mind, teethering of long flexible chains onto the polymer matrices, with high crosslinking density, appears to be an excellent idea to improve the bioadhesive property. In a recent study, this phenomenon was utilized to device tethered  poly  (ethylene  glycol)–poly  (acrylic  acid)  hydrogels  with  improved  mucoadhesive properties [24, 32]. In addition to the reduced flexibility of the  polymer chains, crosslinking results in the reduced diffusion of water into the crosslinked polymer matrix. But  sufficient hydration of the polymer network is necessary for the complete opening of the interpolymeric pores  within the polymer matrix in addition to the mobilization of the polymer chains [33]. Hence highly crosslinked  polymeric matrix limits the interpenetration of polymer and mucin chains amongst themselves which in turn results in the decrease in the mucoadhesive strength [34]. Apart from the MW and chain length of the polymer  chains, spatial arrangement of the polymer chains may also play an important role. As mentioned above, dextrans of 19,500,000 and 200,000 MW exhibit good mucoadhesive properties. The efficiency of both the dextrans and PEG (MW: 200,000) have been found to possess similar bioadhesive strength [24, 30, 35].

Formation of hydrogen-bonds amongst the functional groups of the polymers and mucosal layer also plays an important role. In general, stronger the hydrogen bonding stronger is the adhesion. The functional groups  responsible for such kind of interaction include hydroxyl, carboxyl and amino groups. Various polymers which have the ability to form strong hydrogen bonds include poly (vinyl alcohol), acrylic derivates, celluloses and starch [36]. Apart from the hydrogen bond formation,  the  presence  of  functional  groups  within  the  polymer  structure  may  render  the polymer chains as polyelectrolytes. The presence of charged functional groups in the polymer chain has a marked effect on the strength of the bioadhesion and can be demonstrated by cell- culture-fluorescent probe technique [37-38]. Anionic polyelectrolytes have been found to form stronger adhesion when compared with neutral polymers [13, 39].
In addition to the above facts, the concentration of the polymer also plays a significant role in the process of mucoadhesion. At lower concentrations of the polymer chains, there is an inadequate and  unstable  interaction   amongst  the  polymer  and  the  mucosal  layer  resulting  in  poor mucoadhesive properties. In general, polymer  concentration in the range of 1-2.5 wt % may exhibit  sufficient  mucoadhesive  property  for  biomedical  applications.  However  for  certain polymers,  like poly (vinyl  pyrrolidone) and  poly (vinyl  alcohol),  solvent  diffusion  into the polymer network decreases at very high polymer concentration due to the formation of the highly coiled structure thereby limiting interpenetration of the polymer and mucin chains with the subsequent reduction in the mucoadhesive property [40].
Apart from the above-mentioned physico-chemical properties of the polymeric network, various environmental  factors also play an important role in mucoadhesion. As mentioned previously, mucoadhesive property is dependent on the presence of functional groups which can ionize so as to give a charge distribution on the polymer  chains. The ionization of the functional group is dependent  on  the  pH  of  the  external  medium.  Hence  change  in  the  pH  of  the  external environment may play an important role in tailoring mucoadhesive property.  As for example, chitosan (cationic polyelectrolyte) exhibit excellent mucoadhesive property in neutral or alkaline medium [41]. The contact time amongst the polymer matrix and the mucosal layer can also govern the  mucoadhesive property. With the initial increase in the contact time there is an increase in the hydration of the polymer matrix and subsequent interpenetration of the polymer chains. The physiology of the mucosal layer may  vary depending on the patho-physiological nature of the human body. The physiological factors which play an important role in governing the mucoadhesive property of a polymer matrix include texture and thickness of mucosa [36].

EVALUATION OF MUCOADHESIVE PROPERTIES
Various in vivo and in vitro methods are used for testing the efficacy of the mucoadhesive nature of  a  polymer  matrix.  Commonly  used  in  vitro/  ex  vivo  methods  include  tensile  strength measurement, shear strength  measurement and chip based systems whereas various imaging techniques are used for the evaluation of the  delivery systems under in vivo conditions. This section will describe various methods used to study the mucoadhesive properties.
In vitro tensile strength measurement is done by dipping a filter paper in 8% mucin dispersion. Thereafter,  the  mucin  coated  filter  paper  is  placed  in  contact  with  the  hydrated  polymeric samples (in physiological solutions) for a definite period of time, followed by the determination of  the  maximum  force  required  to  detach  the  filter-paper  and  polymer  surfaces  after  the mucoadhesive  bonding  [42].  Similarly,  ex  vivo  experimentations  are  also  done  with  the exception that the mucin coated filter-paper is replaced with excised mucosal tissues (e.g. buccal mucosa, intestinal mucosa, vaginal mucosa) [43-45]. The mucoadhesive properties can also be determined by incubating the hydrated polymer matrix surface kept in contact with a viscoelastic 30 %  (w/w)  mucin  solution  in  water  with  the  subsequent  determination  of  the  maximum detachment force required to separate the polymer matrix and mucin solution surfaces after the adhesion [46]. Wash-off test may  also be used  to determine the mucoadhesive property of delivery systems. In the test, the mucosal tissue is attached onto a glass slide with the help of a double-sided cyanoacrylate tape. Thereafter, the delivery system is  put on the surface of the tissue (exposed mucosal surface) with the subsequent vertical attachment of the system into the USP tablet disintegrator apparatus, which contains 1 L of physiological solution maintained at 37oC. The operation of the equipment gives an up-and-down movement to the tissue-delivery matrix system. In this study, the time for the complete detachment of the delivery system from the mucosal layer is determined [47]. For the relative measurement of mucoadhesive nature of powder  polymer  samples  modified  Du  Noüy tensiometer  may be  used,  while  in  the  shear strength determination method the force required to  slide the polymer matrix over the mucus layer  is  determined  [45].  Recently  mucoadhesion  studies  have   been  reported  by  using BIACORE®  integrated chip (IC) systems. The method involves immobilization of the polymer (powder) on to the surface of the IC with the subsequent passage of the mucin solution over the same. This results in the interaction of the mucin with that of the polymer surface. The polymer- mucin interaction is measured by an  optical phenomenon called Surface Plasmon Resonance (SPR), which measures the change in the refractive  index when mucin binds on the polymer surface [48]. The in vivo experiments involve the administration of radioactive labeled delivery system with the subsequent measurement of radioactivity in the tissues, at regular intervals of time, where the delivery system is supposed to adhere. The higher the radioactivity, the higher is the mucoadhesive property of the designed delivery system [48-50].

SITES FOR MUCOADHESIVE DRUG DELIVERY SYSTEMS
The common sites of application where mucoadhesive polymers have the ability to delivery pharmacologically active agents include oral cavity, eye conjunctiva, vagina, nasal cavity and gastrointestinal tract. The current  section of the review will give an overview of the above- mentioned delivery sites.
The buccal cavity has a very limited surface area of around 50 cm2  but the easy access to the site makes it a preferred location for delivering active agents. The site provides an opportunity to deliver pharmacologically active agents systemically by avoiding hepatic first-pass metabolism in addition to the local treatment of the oral lesions. The sublingual mucosa is relatively more permeable than the buccal mucosa (due to the presence of large number of smooth muscle and immobile mucosa), hence formulations for sublingual delivery are designed to release the active agent quickly while mucoadhesive formulation is of importance for the delivery of active agents to the buccal mucosa where the active agent has to be released in a controlled manner. This makes  the  buccal  cavity  more  suitable  for  mucoadhesive  drug  delivery  [51].  The  various mucoadhesive   polymers  used  for  the  development  of  buccal  delivery  systems  include cyanoacrylates,    polyacrylic    acid,    sodium    carboxymethylcellulose,    hyaluronic    acid, hydroxypropylcellulose, polycarbophil, chitosan and gellan [24, 52]. The delivery systems are generally coated  with a drug and water impermeable film so as to prevent the washing of the active agent by the saliva [24].
Like  buccal  cavity,  nasal  cavity  also  provides  a  potential  site  for  the  development  of formulations where mucoadhesive polymers can play an important role. The nasal mucosal layer has a surface area of around 150-200 cm2. The residence time of a particulate matter in the nasal mucosa varies between 15 and 30 min, which have been attributed to the increased activity of the mucociliary  layer  in  the  presence  of  foreign  particulate  matter.  The  polymers  used  in  the development of formulations for the development of nasal delivery system include copolymer of methyl vinyl ether, hydroxypropylmethylcellulose,  sodium carboxymethylcellulose, carbopol-934P and Eudragit RL-100 [53-54].

Due to the continuous formation of tears and blinking of eye lids there is a rapid removal of the active medicament from the ocular cavity, which results in the poor bioavailability of the active agents. This can be minimized by delivering the drugs using ocular insert or patches [24]. The mucoadhesive  polymers  used  for  the  ocular  delivery  include  thiolated  poly(acrylic  acid), poloxamer, celluloseacetophthalate, methyl cellulose, hydroxy ethyl cellulose, poly(amidoamine) dendrimers, poly(dimethyl siloxane) and poly (vinyl pyrrolidone) [55-57].
The vaginal and the rectal lumen have also been explored for the delivery of the active agents both systemically and locally. The active agents meant for the systemic delivery by this route of administration  bypasses  the hepatic  first-pass  metabolism.  Quite often  the delivery systems suffer from migration within the vaginal/rectal lumen  which might affect the delivery of the active agent to the specific location. The use of mucoadhesive polymers for the development of delivery system helps in reducing the migration of the same thereby promoting better therapeutic efficacy. The polymers used in the development of vaginal and rectal delivery systems include mucin, gelatin, polycarbophil and poloxamer [58-60].
Gastrointestinal  tract  is  also  a  potential  site  which  has  been  explored  since  long  for  the development of  mucoadhesive based formulations. The modulation of the transit time of the delivery systems in a particular location of the gastrointestinal system by using mucoadhesive polymers has generated much interest among  researchers around the world [61]. The various mucoadhesive polymers which have been used for the  development of oral delivery systems include chitosan, poly (acrylic acid), alginate, poly (methacrylic acid) and sodium carboxymethyl cellulose [62].

NOW YOU CAN ALSO PUBLISH YOUR ARTICLE ONLINE.

SUBMIT YOUR ARTICLE/PROJECT AT articles@pharmatutor.org

Subscribe to Pharmatutor Alerts by Email

FIND OUT MORE ARTICLES AT OUR DATABASE

POLYMERS IN MUCOSAL DRUG DELIVERY
Mucoadhesive delivery systems are being explored for the localization of the active agents to a particular location/ site. Polymers have played an important role in designing such systems so as to increase the residence  time of the active agent at the desired location. Polymers used in mucosal delivery system may be of natural or synthetic origin. In this section we will briefly discuss some of the common classes of mucoadhesive polymers.

Hydrophilic polymers
The polymers within this category are soluble in water. Matrices developed with these polymers swell  when  put   into  an  aqueous  media  with  subsequent  dissolution  of  the  matrix.  The polyelectrolytes extend greater  mucoadhesive property when compared with neutral polymers [63]. Anionic polyelectrolytes, e.g. poly (acrylic acid) and carboxymethyl cellulose, have been extensively used for designing mucoadhesive delivery systems  due  to their ability to exhibit strong hydrogen bonding with the mucin present in the mucosal layer [24, 64]. Chitosan provides an excellent example of cationic polyelectrolyte, which has been extensively used for developing mucoadhesive  polymer  due  to  its  good  biocompatibility and  biodegradable  properties  [65]. Chitosan undergoes electrostatic interactions with the negatively charged mucin chains thereby exhibiting  mucoadhesive  property  [63].  The  ionic  polymers  may  be  used  to  develop  ionic complex with the counter-ionic drug molecules so as to have a drug delivery matrix exhibiting mucoadhesive property. In a recent study, partially neutralized poly (acrylic acid) complex was developed  in  the  presence  of  levobetaxolol  hydrochloride,  a  potent  cardiac  β-blocker.  The delivery system  was  prone to  dissolution  as  the time progressed  due  to  the  release of the incorporated drug [66]. Mucoadhesive microcapsules can be designed with same principle by using orifice-ionic gelation method. This technique has been used to design a delivery system of gliclazide,  an  anti-diabetic  drug,  using  sodium  alginate,  sodium  carboxymethyl  cellulose, carbopol 934P and hydroxy propylmethyl cellulose. The delivery system showed the release of gliclazide for an extended period of time due  to its mucoadhesive properties [67]. Non-ionic polymers, e.g. poloxamer, hydroxypropyl methyl cellulose, methyl cellulose, poly (vinyl alcohol) and  poly  (vinyl  pyrrolidone),  have  also  been  used  for  mucoadhesive  properties  [63].  The hydrophilic polymers form viscous solutions when dissolved in water and hence may also be used  as  viscosity modifying/enhancing  agents  in  the  development  of  liquid  ocular  delivery systems so as to increase the bioavailability of the active agents by reducing the drainage of the administered formulations [63, 68]. These polymers may be directly compressed in the presence of drugs so as to have a mucoadhesive delivery system [69].

Numerous polysaccharides and its derivatives like chitosan, methyl cellulose, hyaluronic acid, hydroxypropyl methylcellulose, hydroxypropyl cellulose, xanthan gum, gellan gum, guar gum, and  carrageenan  have  found   applications  in  ocular  mucoadhesive  delivery  systems  [63]. Cellulose and its derivates have been reported to have surface active property in addition to its film forming capability [65, 70]. Cellulose derivatives with lower  surface acting property are generally preferred in ocular delivery systems as they cause reduced eye irritation. Of the various cellulose derivates, sodium carboxymethyl cellulose has been found to have excellent ocular mucoadhesive property. Cationic cellulose derivatives (e.g. cationic hydroxyethyl celluloses) have been used in conjunction with various anionic polymers for the development of sustained delivery systems [63, 71].

Hydrogels
Hydrogels can be defined as three-dimensionally crosslinked polymer chains which have the ability to hold water within its porous structure. The water holding capacity of the hydrogels is mainly due to the presence of hydrophilic functional groups like hydroxyl, amino and carboxyl groups. In general, with the increase in the crosslinking density there is an associated decrease in the mucoadhesion [72]. Thielmann et al. reported the thermal crosslinking of poly (acrylic acid) and methyl cellulose. They reported that with the increase in the crosslinking density, there was a reduction  in  the  solubility  parameters  and  swelling  which  resulted  in  a  reduction  of mucoadhesion [72]. Hydrogels prepared by the condensation reaction of poly (acrylic acid) and sucrose indicated an increase in the mucoadhesive property with the increase in the crosslinking density and was attributed to increase in the poly (acrylic acid) chain density per unit area [73]. Acrylates have been used to develop mucoadhesive delivery systems which have the ability to deliver peptide bioactive agents to the upper small  intestine region without any change in the bioactivity of the peptides. In a typical experimentation, Wood and Peppas developed a system in which ethylene glycol chains were grafted on methacrylic acid hydrogels and were subsequently functionalized with wheat germ agglutinin. Wheat germ agglutinin helped in improving the intestinal  residence  time  of  the  delivery  system  by  binding  with  the  specific  carbohydrate moieties present in the intestinal mucosa [74]. In addition to the drug targeting, mucoadhesive hydrogel based formulations for improving the bioavailability of the poorly water soluble drug. Muller and Jacobs prepared a nanosuspension of buparvaquone, a poorly water soluble drug, by incorporating  it  within  carbopol  and  chitosan  based  hydrogels.  The  mucoadhesive  delivery systems showed improved bioavailability of the drug when compared over the nanosuspension. This  was  attributed  to  the   increased  retention  time  of  the  delivery  system  within  the gastrointestinal tract [75].

Thiolated polymers:
The presence of free thiol groups in the polymeric skeleton helps in the formation of disulphide bonds  with  that  of the cysteine-rich  sub-domains  present  in  mucin  which  can  substantially improve the mucoadhesive properties of the polymers (e.g. poly (acrylic acid) and chitosan) in addition to the paracellular uptake of the bioactive agents [76-80]. Various thiolated polymers include chitosan–iminothiolane, poly(acrylic acid)–cysteine,  poly(acrylic acid)–homocysteine, chitosan–thioglycolic    acid,    chitosan–thioethylamidine,    alginate–cysteine,    poly(methacrylic acid)–cysteine and sodium carboxymethylcellulose–cysteine [24].

Lectin-based polymers:
Lectins are proteins which have the ability to reversibly bind with specific sugar / carbohydrate residues and are found in both animal and plant kingdom in addition to various microorganisms [81-83]. Many lectins have been found to be toxic and immunogenic which may lead to systemic anaphylaxis in susceptible individuals on  subsequent exposure [24]. The specific affinity of lectins  towards  sugar  or  carbohydrate  residues  provides  them  with  specific  cyto-adhesive property and is being explored to develop targeted delivery systems. Lectins  extracted from legumes have been widely explored for targeted delivery systems. The various lectins which have  shown specific binding to the mucosa include lectins extracted from Ulex europaeus I, soybean, peanut and Lens culinarius [84]. The use of wheat germ agglutinin has been on the rise due to its least immunogenic reactions, amongst available lectins, in addition to its capability to bind to the intestinal and alveolar epithelium and hence could be used to design oral and aerosol delivery systems [85].

CONCLUSION
Of late, scientists are trying to improve the bioavailability of active agents by tailoring the properties  of  the  delivery  systems  instead  of  designing  new  active  agents.  Mucoadhesive
polymers may provide an important tool to improve the bioavailability of the active agent by improving  the  residence  time  at  the  delivery  site.  The  various  sites  where  mucoadhesive polymers have played an important role include buccal cavity, nasal cavity, rectal lumen, vaginal lumen and gastrointestinal tract. Development of novel mucoadhesive delivery systems are being undertaken  so  as  to  understand  the  various  mechanism  of   mucoadhesion  and  improved permeation of active agents. Many potential mucoadhesive systems are being investigated which may find their way into the market in near future.

References:
1.  Webster’s Encyclopedic Unabridged Dictionary of the English Language. Thunder Bay Press, Avenel (NJ, USA), 2001.
2.  Kaelbe D H and Moacanin J. A surface energy analysis of bioadhesion. Polym., 18, 1977, pp. 475-481.
3.  Gu J M, Robinson J R and Leung S. Binding of acrylic polymers to mucin/epithelial surfaces; Structure-property-relationship. Crit. Rev. Ther. Drug Car. Sys. 5, 1998, pp. 21-67.
4.  Duchene  D,  Touchard  F  and  Peppas  N  A.  Pharmaceutical  and  medical  aspects  of Bioadhesive system for drug administration. Drug Dev. Ind. Pharm., 14, 1998, pp. 283-381.
5.  Hollingsbee D A and Timmins P. Topical adhesive system, in Bioadhesion Possibilities and  Future   Trends,  Gurny  R  and  Junginger  H  E  Eds.,  Wissenchaftliche  verlag Gesellschaft, Stuttgart, 1990, pp. 140-164.
6.  Wang P Y. Surgical adhesive and coating in medical engineering.  Ray C D Eds., Year book Medical Publisher, Chicago, USA, 1974, pp. 1123-1128.
7.  Harper    C M and Ralston M. Isobutyl 2-cyanoacrylate as an osseous adhesive in the repair of osteochondral fracture. J. Biomed Mat. Res., 17, 1983, pp. 167-177.
8.  Silver T H, Librizzi J, Pins G, Wang M C and Benedetto D. Physical properties of hyaluronic acid and hydroxypropylmethylcellulose in sol; Evaluation of coating abilities. J. Appl.  Biomat. l5, 1979, pp. 89-98.
9.  Beachy E H. Bacterial adherence, series B, Vol 6, Chapman and Hall, London and New York, 1980.
10. Boedecker E C. Attachment of organism to the gut mucosa. Vol I and II, CRC Press, Boca Raton, Florida, 1984.
11. Mergenhagen, S. E. and Rosan, B., Molecular basis of oral microbial adhesion. Am. Soc. Microbio., 1985, Washington D.C.
12. Horstedt P, Danielsson A, Nyhlin H, Stenling R and Suhr O. Adhesion of bacteria to the human small intestinal mucosa. Scandinavian J. Gastroenterology, 24, 1989, pp. 877-885.
13. Peppas  N  A  and  Buri  P  A.  Surface,  interfacial  and  molecular  aspects  of  polymer bioadhesion on soft  tissues. J. Control. Release., 2,  1985, pp. 257-275.
14. Woodley    J.    Bioadhesion:    New    Possibilities    for    Drug    Administration.    Clin. Pharmacokinet., 40 (2), 2001, pp. 77-84.
15. Harding  SE,  Davis  SS,  Deacon  MP  and  Fiebrig  I.  Biopolymer  mucoadhesives. Biotechnol. Genet. Eng. Rev. 16, 1999, pp. 41-86.
16. Scrivener C A and Schantz C W. Penicillin: new methods for its use in dentistry. J. Am. Dental Assoc., 35, 1947, pp. 644-647.
17. Rothner J T, Cobe H M, Rosenthal S L and Bailin J. Adhesive penicillin ointment for topical application. J. Dent. Res., 28, 1949, pp. 544-548.
18. Keutscher A H, Zegarelli E V, Beube F E, Chiton N W. A new vehicle (Orabase) for the application of drugs to the oral mucus membranes, Oral Pathol., 12, 1959, pp. 1080-1089.
19. Chen J L and Cyr G N. Compositions producing adhesion through hydration, in Adhesion in Biological Systems, Manly R S Eds, Academic Press, New York, 1970, pp.163-167.
20. Park J B. Acrylic bone cement: in vitro and in vivo property-structural relationship: a selective review. Ann. Biomed. Eng., 11, 1983, pp. 297–312.
21. Smart J D, Kellaway I W and Worthington H E C. An in vitro investigation of mucosa adhesive materials for use in controlled drug delivery. J. Pharm. Pharmacol., 36, 1984, pp. 295-299.
22. Sudhakar Y, Kuotsu K and Bandyopadhyay A K. Review: Buccal bioadhesive drug delivery    - A promising option for orally less efficient drugs. J. Control. Release, 114, 2006, pp. 15-40.
23. Smart J D. The basics and underlying mechanisms of mucoadhesion. Adv.Drug Del. Rev., 57, 2005, pp. 1556-1568.

NOW YOU CAN ALSO PUBLISH YOUR ARTICLE ONLINE.

SUBMIT YOUR ARTICLE/PROJECT AT articles@pharmatutor.org

Subscribe to Pharmatutor Alerts by Email

FIND OUT MORE ARTICLES AT OUR DATABASE